SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Amrion (amri)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: coffee221 who wrote (4)5/24/1997 2:11:00 AM
From: Boris Maleshev   of 13
 
Good man. Just be patient, I was expecting profit taking to start mid day today, but I guess not. This is part of the greater small cap revival with Amrion obviously outperforming Russel 2000.
One more positive thing about Amrion that came to mind. Not only does this stock has low valuations and high growth, but it also offers long term security. Unlike many small caps that stake their future on one or two technological products that can become obsolete at the whim of Intel or Microsoft, Amrion has a diversified line of products in the business that rarely undergoes any major shake ups. I doubt people around the world will stop aiding their health with vitamins and supplements any time soon.
Target prices: 25% growth rate times projected 98 earnings gives 39.75, I guess by beggining of fiscal 1998.
Enjoy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext